Article Information
History
- May 5, 2021.
Article Versions
- Version 1 (April 23, 2021 - 20:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ghooi Ravindra, Ph.D.1,*,
- Lele Chitra, Ph.D.1,
- Motwani Madhur, Ph.D.1,
- Dixit Santosh, Ph.D.1,
- Premnath Venugopalan, Ph.D.1,
- Salvi Sundeep, M.D., Ph.D.2,
- Bhat Shreepad, M.D.3,
- Chaudhari Piyush, D.N.B.4,
- D’Costa Pradeep, D.N.B.5,
- Jahagirdar Ashwini, M.D.5,
- Mane Abhay, M.D.3,
- Padbidri Vikram, M.D.4,
- Pande Chetan, M.D.5 and
- Shukla Urvi, M.D.6
- 1Task Force on Repurposing Drugs for Covid 19 (TFORD), Venture Centre, Pune
- 2Pulmocare Research and Education (PURE) Foundation, Pune
- 3Smt. Kashibai, Navale Medical College and General Hospital, Narhe, Pune
- 4Jehangir Hospital, Pune
- 5Sahyadri Superspeciality Hospitals, Pune
- 6Symbiosis University Hospital and Research Centre, Lavale, Pune
- ↵*Corresponding Author ravindra.ghooi{at}gmail.com